UroGen presents at Guggenheim Healthcare Talks on Feb 8, 2024; no specific facts in filing

UroGen Pharma Ltd.

Furnished a corporate presentation under Item 7.01 for the Guggenheim Healthcare Talks Conference on February 8, 2024.
Presentation titled 'Developing Innovative Medicines to Treat Urothelial Cancers' – text of exhibit does not include detailed updates.
No financial results, pipeline milestones, or guidance changes disclosed in the filing.
UroGen's stock ticker is URGN; presentation is for investor audiences only.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.